DexCom
DXCM
275 hedge funds and large institutions have $4.97B invested in DexCom in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 120 increasing their positions, 82 reducing their positions, and 61 closing their positions.
63% more call options, than puts
Call options by funds: $30.7M | Put options by funds: $18.8M
46% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 82
18.04% more ownership
Funds ownership: 452.39% → 470.43% (+18%)
11% less funds holding
Funds holding: 310 → 275 (-35)
30% less capital invested
Capital invested by funds: $7.14B → $4.97B (-$2.17B)
51% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 61
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$458M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$158M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$141M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$107M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$100M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$277M |
| 2 |
Bank of New York Mellon
New York
|
-$160M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$145M |
| 4 |
FAM
Fred Alger Management
New York
|
-$135M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$113M |
DXCM Hedge Fund Activity: Q3 2017 in Review
275 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2017, worth a combined $4.97B — down 30% from $7.14B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of DXCM and 30 opened new positions — a net loss of 31 holders — while 82 trimmed existing stakes and 120 added.
The largest buyer was Wellington Management Group, adding an estimated $458M. The largest seller was Ameriprise, cutting an estimated $277M.
- 275 institutional investors held DexCom (DXCM) as of Q3 2017, down from 310 in Q2 2017.
- Funds reported $4.97B of DexCom stock for Q3 2017, down 30% quarter-over-quarter.
- 30 funds opened new DexCom positions in Q3 2017 and 61 closed out, a net change of -31 holders.
- The largest DexCom buyer in Q3 2017 was Wellington Management Group, an estimated $458M added.
- The largest DexCom seller in Q3 2017 was Ameriprise, an estimated $277M sold.
Based on aggregated 13F filings for Q3 2017.